Cited by 319Retinoids in leukemia and cellular processesPeroxisome Proliferator-Activated ReceptorsAcute Myeloid Leukemia Research

The DOI matches its Crossref record.

Continuous treatment with all-trans retinoic acid causes a progressive reduction in plasma drug concentrations: implications for relapse and retinoid "resistance" in patients with acute promyelocytic leukemia [published erratum appears in Blood 1992 Aug 1;80(3):855]

Open access

Muindi, J, Frankel, SR, Miller, WH Jr, Jakubowski, A, Scheinberg, DA, Young, CW, Dmitrovsky, E, Warrell, RP Jr·1992·Blood

DOI 10.1182/blood.v79.2.299.299

Open this paper in CoChat — free account Open PDF

Abstract

Although all-trans retinoic acid (RA) induces complete remission in a high proportion of patients with acute promyelocytic leukemia (APL), all groups have described clinical relapses despite continued RA treatment. This finding suggests that resistance to the cytodifferentiating effects of the retinoid had been acquired. To investigate potential mechanisms of clinical resistance to RA, we serially evaluated the clinical pharmacology of the drug in APL patients treated with this agent. Leukemic cells from patients relapsing from RA treatment were cultured in the presence of RA and examined for evidence of morphologic maturation. We also studied messenger RNA expression of the newly described gene product of the (15;17) translocation in APL, PML/RA receptor-alpha (PML/RAR-alpha). Serial pharmacokinetic studies showed that continuous daily RA treatment was associated with a marked decrease in plasma drug concentrations at the time of relapse compared with the initial day of therapy. Doubling the RA dose in six patients failed to reinduce response at the time of relapse and also failed to significantly augment plasma RA concentrations. However, leukemic cells obtained at the time of relapse from four patients retained in vitro sensitivity to the differentiating activity of RA (10(-6) mol/L). No change was observed in the pattern of PML/RAR-alpha expression assessed by Northern blot analysis at the time of relapse compared with pretreatment in two patients who were tested. These results indicate that clinical relapse and “resistance” to continuous treatment with all- trans RA in APL is associated with progressive reduction of plasma concentrations, potentially to levels below those that sustain differentiation of leukemic cells in vivo. Long-term success of this treatment will require the development of strategies that circumvent this pharmacologic phenomenon.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1182/blood.v79.2.299.299

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The publisher hasn’t deposited this paper’s reference list.

Research works printed but not linked: 2

Brazzell RK, Colburn WA: Pharmacokinetics of the retin- oids isotretinoin and etretinate: A comparative review. J Am Acad Dermatol6:643, 1982
Francis PA, Riggs JR, Muindi JR, Kris MG, Young CW, Warrell RP Jr: Modulation of all-trans retinoic acid (RA) pharma- cokinetics by a cytochrome P-450 enzyme system inhibitor. Proc Am Soc Clin Oncol (in press)

Sorted by citations

Items 101–200 of 319

A Comparison of Gene Expression Responses in Rat Whole Embryo Culture and In Vivo: Time-Dependent Retinoic Acid-Induced Teratogenic Response
Robinson, J. F., Verhoef, A., Pennings, J. L. A., Pronk, T. E., & Piersma, A. H. (2012) · Toxicological Sciences · doi:10.1093/toxsci/kfr342 · Cited by 35
Spray-drying of oil-in-water emulsions for encapsulation of retinoic acid: Polysaccharide- and protein-based microparticles characterization and controlled release studies
Gonçalves, A., Estevinho, B. N., & Rocha, F. A. (2021) · Food Hydrocolloids · doi:10.1016/j.foodhyd.2021.107193 · Cited by 35
Retinoids in the Pathogenesis and Treatment of Liver Diseases
Melis, M., Tang, X., Trasino, S. E., & Gudas, L. J. (2022) · Nutrients · doi:10.3390/nu14071456 · Cited by 37
Development of Inhalable ATRA-Loaded PLGA Nanoparticles as Host-Directed Immunotherapy against Tuberculosis
Bahlool, A. Z., Fattah, S., O’Sullivan, A., Cavanagh, B., MacLoughlin, R. J., Keane, J., O’Sullivan, M. P., & Cryan, S. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14081745 · Cited by 36
Molecular targeting of retinoic acid metabolism in neuroblastoma: the role of the CYP26 inhibitor R116010 in vitro and in vivo
Armstrong, J., Taylor, G. A., Thomas, H. D., Boddy, A., Redfern, C. P., & Veal, G. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603779 · Cited by 1,238
Anticancer activity and mechanism of action of retinoids in oral and pharyngeal cancer
Klaassen, I., & Braakhuis, B. J. M. (2002) · Oral Oncology · doi:10.1016/s1368-8375(01)00118-x · Cited by 35
The Promise of Retinoids in the Treatment of Cancer: Neither Burnt Out Nor Fading Away
Nagai, Y., & Ambinder, A. J. (2023) · Cancers · doi:10.3390/cancers15143535 · Cited by 35
Inhibition of metastatic lung cancer in C57BL/6 mice by liposome encapsulated all trans retinoic acid (ATRA)
SiddikUzzaman, B. S. P., & Grace, V. M. B. (2012) · International Immunopharmacology · doi:10.1016/j.intimp.2012.09.008 · Cited by 34
Human lung cancer and hexavalent chromium exposure.
Halášová, E., Matáková, T., Kavcová, E., Mušák, Ľ., Letková, L., Adamkov, M., Ondrušová, M., Bukovska, E., & Singliar, A. (2009) · PubMed · Cited by 34
Anti-tumor activity of all-trans retinoic acid-incorporated glycol chitosan nanoparticles against HuCC-T1 human cholangiocarcinoma cells
Chung, K. D., Jeong, Y., Chung, C., Kim, D. H., & Kang, D. H. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.10.057 · Cited by 33
Pin1 inhibition exerts potent activity against acute myeloid leukemia through blocking multiple cancer-driving pathways
Lian, X., Lin, Y., Kozono, S., Herbert, M. K., Li, X., Yuan, X., Guo, J., Guo, Y., Tang, M., Lin, J. L., et al. (2018) · Journal of Hematology & Oncology · doi:10.1186/s13045-018-0611-7 · Cited by 33
All-trans retinoic acid-associated low molecular weight water-soluble chitosan nanoparticles based on ion complex
Kim, D.-G., Choi, C., Jeong, Y.-I., Jang, M.-K., Nah, J.-W., Kang, S.-K., & Bang, M.-S. (2006) · Macromolecular Research · doi:10.1007/bf03219070 · Cited by 33
Management of acute promyelocytic leukemia
Fenaux, P. (1993) · European Journal Of Haematology · doi:10.1111/j.1600-0609.1993.tb00144.x · Cited by 33
Altered metabolism of all-trans-retinoic acid in liposome-encapsulated form
Parthasarathy, R. V., & Mehta, K. (1998) · Cancer Letters · doi:10.1016/s0304-3835(98)00226-2 · Cited by 33
Clinical aspects of acute myeloid leukemias of the FAB types M3 and M4Eo
Haferlach, T., Gassmann, W., Löffler, H., et al. (1993) · Annals of Hematology · doi:10.1007/bf01703230 · Cited by 33
Pharmacokinetics and therapeutic efficiency of a novel cationic liposome nano-formulated all trans retinoic acid in lung cancer mice model
Grace, V. M. B., & Viswanathan, S. (2017) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2017.04.005 · Cited by 32
Inhibition of liver metastasis by all-trans retinoic acid incorporated into O/W emulsions in mice
Chansri, N., Kawakami, S., Yamashita, F., & Hashida, M. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.05.008 · Cited by 32
Formulation andin-vitrocharacterization of retinoic acid loaded poly (lactic-co-glycolic acid) microspheres
Çırpanlı, Y., Ünlü, N., Çalış, S., & Hıncal, A. A. (2005) · Journal of Microencapsulation · doi:10.1080/02652040500273878 · Cited by 31
Treatment of Newly Diagnosed Acute Promyelocytic Leukemia (APL) by All Transretinoic Acid (ATRA) Combined with Chemotherapy: The European Experience
Fenaux, P., Chastang, C., Chomienne, C., et al. (1995) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428199509054430 · Cited by 32
Choice of chemotherapy in induction, consolidation and maintenance in acute promyelocytic leukaemia
Sanz, M. Á., Martı́n, G., & Lo‐Coco, F. (2003) · Best Practice & Research Clinical Haematology · doi:10.1016/s1521-6926(03)00040-9 · Cited by 32
Untitled work
(1995) · doi:10.1002/1097-0142(19950815)76:4
Self-citation
Role of mesenchymal-epithelial interactions in normal and abnormal development of the mammary gland and prostate
Cunha, G. R. (1994) · Cancer · doi:10.1002/1097-0142(19940801)74:3+ · Cited by 324
Pin1‐Targeted Therapy for Systemic Lupus Erythematosus
Wei, S., Yoshida, N., Finn, G., Kozono, S., Nechama, M., Kyttaris, V. C., Zhou, X. Z., Tsokos, G. C., & Lu, K. P. (2016) · Arthritis & Rheumatology · doi:10.1002/art.39741 · Cited by 31
Synthetic Retinoids Beyond Cancer Therapy
Gudas, L. J. (2021) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-052120-104428 · Cited by 34
Retinoids Activate the RXR/SXR-Mediated Pathway and Induce the Endogenous CYP3A4 Activity in Huh7 Human Hepatoma Cells
Wang, K., Mendy, A. J., Dai, G., Luo, H., He, L., & Wan, Y. Y. (2006) · Toxicological Sciences · doi:10.1093/toxsci/kfj207 · Cited by 31
A Randomized Comparison of All Transretinoic Acid (ATRA) Followed by Chemotherapy and ATRA Plus Chemotherapy and the Role of Maintenance Therapy in Newly Diagnosed Acute Promyelocytic Leukemia
Fenaux, P., Chastang, C., Chevret, S., et al. (1999) · Blood · doi:10.1182/blood.v94.4.1192.416k07_1192_1200 · Cited by 31
The molecular genetics of acute promyelocytic leukemia
Grignani, F., Fagioli, M., Ferrucci, P. F., et al. (1993) · Blood Reviews · doi:10.1016/s0268-960x(05)80018-9 · Cited by 31
Potential of retinoic acid derivatives for the treatment of corticotroph pituitary adenomas
Labeur, M. S., Páez-Pereda, M., ARZT, E. S., & Stalla, G. K. (2008) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-008-9080-6 · Cited by 30
Belinostat, a potent HDAC i, exerts antileukaemic effect in human acute promyelocytic leukaemia cells via chromatin remodelling
Valiulienė, G., Stirblytė, I., Cicenaite, D., Kaupinis, A., Valius, M., & Navakauskienė, R. (2015) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12550 · Cited by 30
Anticancer and superoxide scavenging activities of p-alkylaminophenols having various length alkyl chains
Takahashi, N. K., Honda, T., & Ohba, T. (2005) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2005.08.016 · Cited by 29
Restoration of Retinoid Sensitivity by MDR1 Ribozymes in Retinoic Acid–Resistant Myeloid Leukemic Cells
Matsushita, H., Kizaki, M., Kobayashi, H., et al. (1998) · Blood · doi:10.1182/blood.v91.7.2452 · Cited by 29
The Retinoids: Cancer Therapy and Prevention Mechanisms
Nason-Burchenal, K., & Dmitrovsky, E. (1999) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-58483-1_10 · Cited by 30
Self-citation
Inhibitory effects of retinoic acid metabolism blocking agents (RAMBAs) on the growth of human prostate cancer cells and LNCaP prostate tumour xenografts in SCID mice
Huynh, C., Brodie, A. M., & Njar, V. C. O. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6602971 · Cited by 28
Cytodifferentiation by Retinoids, a Novel Therapeutic Option in Oncology: Rational Combinations with Other Therapeutic Agents
Garattini, E., Gianni’, M., & Terao, M. (2007) · Vitamins and hormones · doi:10.1016/s0083-6729(06)75012-9 · Cited by 28
Characterization of biopolymer-based systems obtained by spray-drying for retinoic acid controlled delivery
Gonçalves, A., Estevinho, B. N., & Rocha, F. A. (2019) · Powder Technology · doi:10.1016/j.powtec.2019.01.062 · Cited by 27
Altered Sensitivity to Retinoid-Induced Apoptosis Associated with Changes in the Subcellular Distribution of Bcl-2
Bruel, A., Karsenty, E., Schmid, M., et al. (1997) · Experimental Cell Research · doi:10.1006/excr.1997.3594 · Cited by 27
Antioxidant and anticancer activities of novel p-alkylaminophenols and p-acylaminophenols (aminophenol analogues)
Takahashi, N. K., Ohba, T., Yamauchi, T., et al. (2006) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2006.05.013 · Cited by 26
Phase II Trial of All-Trans Retinoic Acid in Metastatic Non-Small Cell Lung Cancer
Treat, J., Friedland, D., Luginbuhl, W. E., et al. (1996) · Cancer Investigation · doi:10.3109/07357909609018898 · Cited by 26
Self-citation
All trans retinoic acid as a host-directed immunotherapy for tuberculosis
Bahlool, A. Z., Grant, C., Cryan, S., Keane, J., & O’Sullivan, M. P. (2022) · Current Research in Immunology · doi:10.1016/j.crimmu.2022.03.003 · Cited by 28
Maintenance of retinoic acid receptor alpha pools by granulocyte colony-stimulating factor and lithium chloride in all-trans retinoic acid–treated WEHI-3B leukemia cells: relevance to the synergistic induction of terminal differentiation
Finch, R. A., Li, J., Chou, T., & Sartorelli, A. C. (2000) · Blood · doi:10.1182/blood.v96.6.2262.h8002262_2262_2268 · Cited by 25
Revealing the Potential Application of EC-Synthetic Retinoid Analogues in Anticancer Therapy
Abdelaal, M. R., Soror, S. H. A., Elnagar, M. R., & Haffez, H. (2021) · Molecules · doi:10.3390/molecules26020506 · Cited by 24
Phase I trial of interferon α2b and liposome‐encapsulated all‐trans retinoic acid in the treatment of patients with advanced renal cell carcinoma
Goldberg, J. S., Vargas, M., Rosmarin, A. S., Milowsky, M. I., Papanicoloau, N., Gudas, L. J., Shelton, G., Feit, K., Petrylak, D. P., & Nanus, D. M. (2002) · Cancer · doi:10.1002/cncr.10809 · Cited by 24
Practice Points, Consensus, and Controversial Issues in the Management of Patients with Newly Diagnosed Acute Promyelocytic Leukemia
Sanz, M. Á., Tallman, M. S., & Lo‐Coco, F. (2005) · The Oncologist · doi:10.1634/theoncologist.10-10-806 · Cited by 23
Retinoid Resistance in Leukemic Cells
Kizaki, M., Ueno, H., Matsushita, H., Takayama, N., Muto, A., Awaya, N., & Ikeda, Y. (1997) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428199709039029 · Cited by 21
Molecular analysis of the t(15;17) translocation in acute promyelocytic leukaemia
Borrow, J., & Solomon, E. (1992) · Baillière s Clinical Haematology · doi:10.1016/s0950-3536(11)80048-x · Cited by 22
Dexamethasone plus retinoids decrease IL‐6/IL‐6 receptor and induce apoptosis in myeloma cells
Smith, M. R., Xie, T., Joshi, I. D., & Schilder, R. J. (1998) · British Journal of Haematology · doi:10.1046/j.1365-2141.1998.00850.x · Cited by 23
Retinoids—“Differentiation Agents” for Cancer Treatment and Prevention
Hofmann, S. L. (1992) · The American Journal of the Medical Sciences · doi:10.1097/00000441-199209000-00010 · Cited by 22
Co-encapsulation of retinoic acid, curcumin and resveratrol by spray-drying of alginic acid sodium-based emulsions and ethyl cellulose-based solutions: Impact on the co-delivery profiles
Gonçalves, A., Rocha, F. A., & Estevinho, B. N. (2022) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2022.10.207 · Cited by 21
Population Life-course exposure to health effects model (PLETHEM): An R package for PBPK modeling
Pendse, S. N., Efremenko, A. Y., Hack, C. E., et al. (2019) · Computational Toxicology · doi:10.1016/j.comtox.2019.100115 · Cited by 21
Phosphorylation-Dependent Pin1 Isomerization of ATR: Its Role in Regulating ATR’s Anti-apoptotic Function at Mitochondria, and the Implications in Cancer
Makinwa, Y., Musich, P. R., & Zou, Y. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00281 · Cited by 23
Homology Models and Molecular Modeling of Human Retinoic Acid Metabolizing Enzymes Cytochrome P450 26A1 (CYP26A1) and P450 26B1 (CYP26B1)
Karlsson, M. G., Strid, Å., Sirsjö, A., & Eriksson, L. A. (2008) · Journal of Chemical Theory and Computation · doi:10.1021/ct800033x · Cited by 21
Pharmacokinetics of All‐trans Retinoic Acid in Pediatric Patients with Leukemia
Takitani, K., Tamai, H., Morinobu, T., et al. (1995) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1995.tb03070.x · Cited by 21
p53 and MDM2 alterations in osteosarcomas
Lonardo, F., Ueda, T., Huvos, A. G., Healey, J. H., & Ladanyi, M. (1997) · Cancer · doi:10.1002/(sici)1097-0142(19970415)79:8 · Cited by 147
Formulation approaches for improved retinoids delivery in the treatment of several pathologies
Gonçalves, A., Estevinho, B. N., & Rocha, F. A. (2019) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2019.08.014 · Cited by 21
Treatment With a New Synthetic Retinoid, Am80, of Acute Promyelocytic Leukemia Relapsed From Complete Remission Induced by All-trans Retinoic Acid
Tobita, T., Takeshita, A., Kitamura, K., et al. (1997) · Blood · doi:10.1182/blood.v90.3.967.967_967_973 · Cited by 20
Pharmacokinetics and Metabolism of All‐trans‐and 13‐cis‐Retinoic Acid in Pulmonary Emphysema Patients
Muindi, J. R., Roth, M. D., Wise, R. A., et al. (2007) · The Journal of Clinical Pharmacology · doi:10.1177/0091270007309701 · Cited by 20
Self-citation
CYP26 Inhibitor R115866 Increases Retinoid Signaling in Intimal Smooth Muscle Cells
Ocaya, P., Gidlöf, A. C., Olofsson, P. S., Törmä, H., & Sirsjö, A. (2007) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.106.138602 · Cited by 20
Synthesis of LIAZALTM, a retinoic acid metabolism blocking agent (ramba) with potential clinical applications in oncology and dermatology
Freyne, E. J. E., Raeymaekers, A. H. M., Venet, M., Sanz, G., Wouters, W., Coster, R. D., & Wauwe, J. V. (1998) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(98)00004-3 · Cited by 19
Induction of cytochrome P450 3A by retinoids in rat hepatocyte culture
Jurima‐Romet, M., Neigh, S., & Casley, W. (1997) · Human & Experimental Toxicology · doi:10.1177/096032719701600407 · Cited by 20
Induction of Retinoid Resistance by All-Trans Retinoic Acid in Acute Promyelocytic Leukemia After Remission
Cornic, M., & Chomienne, C. (1995) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428199509059615 · Cited by 18
Acute Promyelocytic Leukaemia Cells Resistant to Retinoic Acid Show Further Perturbation of the RARα Signal Transduction System
Dermime, S., Grignani, F., Rogaia, D., et al. (1995) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428199509049768 · Cited by 20
All-trans-Retinoic Acid in Acute Promyelocytic Leukemia
Sanz, M. Á., Martı́n, G., & Díaz-Mediavilla, J. (1998) · New England Journal of Medicine · doi:10.1056/nejm199802053380613 · Cited by 20
First chemical feature-based pharmacophore modeling of potent retinoidal retinoic acid metabolism blocking agents (RAMBAs): Identification of novel RAMBA scaffolds
Purushottamachar, P., Patel, J. B., Gediya, L. K., Clement, O. O., & Njar, V. C. O. (2011) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2011.11.010 · Cited by 19
Retinoid metabolism and transplacental pharmacokinetics in the cynomolgus monkey following a nonteratogenic dosing regimen with all-trans-retinoic acid
Tzimas, G., Nau, H., Hendrickx, A. G., Peterson, P. E., & Hummler, H. (1996) · Teratology · doi:10.1002/(sici)1096-9926(199611)54:5 · Cited by 19
Induction of differentiation of retinoic acid-resistant acute promyelocytic leukemia cells by the combination of all-trans retinoic acid and granulocyte colony-stimulating factor
Higuchi, T., Kizaki, M., & Omine, M. (2003) · Leukemia Research · doi:10.1016/j.leukres.2003.09.014 · Cited by 19
Pharmacokinetics and Pharmacodynamics of 9‐cis‐Retinoic Acid in Healthy Men
Weber, C., & Dumont, E. (1997) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1997.tb04338.x · Cited by 19
Mutation in the ligand-binding domain of the retinoic acid receptor alpha in HL-60 leukemic cells resistant to retinoic acid and with increased sensitivity to vitamin D3 analogs
Doré, B. T., & Momparler, R. L. (1996) · Leukemia Research · doi:10.1016/0145-2126(96)00043-4 · Cited by 19
Clinical Relevance of all-transRetinoic Acid Pharmacokinetics and Its Modulation in Acute Promyelocytic Leukemia
Lazzarino, M., Regazzi, M., & Corso, A. (1996) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428199609054862 · Cited by 19
Determination of orally administered all-trans-retinoic acid in human plasma by high-performance liquid chromatography
Guiso, G., Rambaldi, A., Dimitrova, B., et al. (1994) · Journal of Chromatography B Biomedical Sciences and Applications · doi:10.1016/0378-4347(94)00080-8 · Cited by 19
HPLC method for simultaneous determination of retinoids and tocopherols in human serum for monitoring of anticancer therapy
Krčmová, L. K., Urbánek, L., Solichová, D., Kašparová, M., Vlčková, H., Melichar, B., Sobotka, L., & Solich, P. (2009) · Journal of Separation Science · doi:10.1002/jssc.200900239 · Cited by 18
Evaluation of the Pharmacokinetics of All-Trans-Retinoic Acid (ATRA) in Wistar Rats After Intravenous Administration of ATRA Loaded into Tributyrin Submicron Emulsion and its Cellular Activity on Caco-2 and HepG2 Cell Lines
Su, J., Zhang, N., & Ho, P. C. (2007) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21193 · Cited by 18
Biological features of primary APL blasts: their relevance to the understanding of granulopoiesis, leukemogenesis and patient management
Cassinat, B., & Chomienne, C. (2001) · Oncogene · doi:10.1038/sj.onc.1204761 · Cited by 18
N-4-Hydroxyphenylretinamide Enhances Retinoic Acid-Induced Differentiation and Retinoylation of Proteins in the Human Acute Promyelocytic Leukemia Cell Line, NB4, by a Mechanism That May Involve Inhibition of Retinoic Acid Catabolism
Taimi, M., & Breitman, T. R. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6309 · Cited by 18
Anti-tumor Effect of All-Trans Retinoic Acid Loaded Polymeric Micelles in Solid Tumor Bearing Mice
Chansri, N., Kawakami, S., Yokoyama, M., Yamamoto, T., Charoensit, P., & Hashida, M. (2007) · Pharmaceutical Research · doi:10.1007/s11095-007-9398-x · Cited by 17
Pharmacokinetics, Tissue Distribution, and Toxicology of Tretinoin Incorporated in Liposomes
Lopez‐Berestein, G., Rosenblum, M. G., Sadeghi, T., & Mehta, K. (1994) · Journal of Liposome Research · doi:10.3109/08982109409037066 · Cited by 17
Histone modifications patterns in tissues and tumours from acute promyelocytic leukemia xenograft model in response to combined epigenetic therapy
Valiulienė, G., Treigytė, G., Savickienė, J., Matuzevičius, D., Alksnė, M., Jarašienė, R., Bukelskienė, V., Navakauskas, D., & Navakauskienė, R. (2016) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2016.01.044 · Cited by 16
Targeting PIN 1 exerts potent antitumor activity in pancreatic ductal carcinoma via inhibiting tumor metastasis
Chen, L., Xu, X., Wen, X., et al. (2019) · Cancer Science · doi:10.1111/cas.14085 · Cited by 16
Potent and selective [2-imidazol-1-yl-2-(6-alkoxy-naphthalen-2-yl)-1-methyl-ethyl]-dimethyl-amines as retinoic acid metabolic blocking agents (RAMBAs)
Mulvihill, M. J., Kan, J. L. C., Beck, P., Bittner, M., Cesario, C., Cooke, A. R., Keane, D. M., Nigro, A., Nillson, C., Smith, V., et al. (2005) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2005.01.044 · Cited by 16
Cross-talk Between Retinoic Acid and Interferons: Molecular Mechanisms of Interaction in Acute Promyelocytic Leukemia Cells
Garattini, E., Mologni, L., Ponzanelli, I., & Terao, M. (1998) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428199809057559 · Cited by 16
Retinoids in Clinical Cancer Therapy
Muindi, J. R. (1996) · Cancer treatment and research · doi:10.1007/978-1-4613-1267-3_13 · Cited by 16
Self-citation
The potential roles of retinoids in combating drug resistance in cancer: implications of ATP-binding cassette (ABC) transporters
Abdelaal, M. R., & Haffez, H. (2022) · Open Biology · doi:10.1098/rsob.220001 · Cited by 15
All-trans retinoic acid loaded block copolymer nanoparticles efficiently induce cellular differentiation in HL-60 cells
Tiwari, M. D., Mehra, S., Jadhav, S., & Bellare, J. (2011) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2011.10.014 · Cited by 16
Integration of toxicological approaches with “omic” and related technologies to elucidate mechanisms of carcinogenic action: Propiconazole, an example
Nesnow, S. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.11.003 · Cited by 15
Modulating T-cell-based cancer immunotherapy via particulate systems
Truong, D. H., Tran, T. T. P., Nguyen, H. T., Phung, C. D., Pham, T. T., Yong, C. S., Kim, J. O., & Tran, T. H. (2018) · Journal of drug targeting · doi:10.1080/1061186x.2018.1474360 · Cited by 15
Involvement of insulin-like growth factor binding protein-3 in the retinoic acid receptor-α-mediated inhibition of hepatocellular carcinoma cell proliferation
Murakami, K., Matsuura, T., HASUMURA, S., et al. (2000) · Cancer Letters · doi:10.1016/s0304-3835(99)00410-3 · Cited by 15
Transcript profiling of cytochrome P450 genes in HL-60 human leukemic cells: Upregulation of CYP1B1 by all-trans-retinoic acid
Kawai, M., Chen, J., Cheung, C. Y. S., & Chang, T. K. H. (2003) · Molecular and Cellular Biochemistry · doi:10.1023/a:1024101430363 · Cited by 15
Microencapsulation of retinoic acid by atomization into biopolymeric matrices: Binary and ternary blends of alginic acid sodium, xanthan gum and modified chitosan
Gonçalves, A., Estevinho, B. N., & Rocha, F. A. (2021) · Food Hydrocolloids · doi:10.1016/j.foodhyd.2021.107310 · Cited by 14
Acute promyelocytic leukemia
Douer, D. (2000) · Current Treatment Options in Oncology · doi:10.1007/s11864-000-0013-1 · Cited by 14
All‐trans retinoic acid at low concentration directly stimulates normal adult megakaryocytopoiesis in the presence of thrombopoietin or combined cytokines
Visani, G., Ottaviani, E., Zauli, G., et al. (1999) · European Journal Of Haematology · doi:10.1111/j.1600-0609.1999.tb01762.x · Cited by 14
Novel Cellular Functions of ATR for Therapeutic Targeting: Embryogenesis to Tumorigenesis
Biswas, H., Makinwa, Y., & Zou, Y. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241411684 · Cited by 13
On-line concentration and determination of all-trans- and 13-cis- retinoic acids in rabbit serum by application of sweeping technique in micellar electrokinetic chromatography
Zhao, Y., Kong, Y., Wang, B., et al. (2007) · Journal of Chromatography A · doi:10.1016/j.chroma.2007.02.022 · Cited by 13
Hyaluronic acid-coated nanoemulsions loaded with a hydrophobic ion pair of all-trans retinoic acid for improving the anticancer activity
Tinoco, L. M. D. S., da Silva, F. L. O., Ferreira, L. A. M., Leite, E. A., & Carneiro, G. (2018) · Brazilian Journal of Pharmaceutical Sciences · doi:10.1590/s2175-97902018000417361 · Cited by 14
Cytokeratins 16 and 10 bind to retinoic acid covalently in skin tissue of mice
Takahashi, N. K., & Fujiu, Y. (2009) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2009.09592.x · Cited by 13
Micellar complexes of all-trans retinoic acid with polyvinylalcohol-nicotinoyl esters as new parenteral formulations in neuroblastoma
Zuccari, G., Bergamante, V., Carosio, R., et al. (2009) · Drug Delivery · doi:10.1080/10717540902757499 · Cited by 13
Differentiation Therapy of Acute Promyelocytic Leukemia: Clinical and Molecular Features
Miller, W. H. (1996) · Cancer Investigation · doi:10.3109/07357909609018889 · Cited by 13
Self-citation
A developmental toxicity study of tretinoin emollient cream (Renova) applied topically to New Zealand white rabbits
Christian, M. S., Mitala, J., Powers, W. J., et al. (1997) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(97)70062-8 · Cited by 13
A Potential Use of a Synthetic Retinoid TAC‐101 as an Orally Active Agent That Blocks Angiogenesis in Liver Metastases of Human Stomach Cancer Cells
Oikawa, T., Murakami, K., Sano, M., et al. (2001) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.2001.tb02144.x · Cited by 13
pH-sensitive niosomes for ATRA delivery: A promising approach to inhibit Pin1 in high-grade serous ovarian cancer
Giuli, M. V., Hanieh, P. N., Forte, J., et al. (2023) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2023.123672 · Cited by 12
Design and synthesis of (E)-1-((3-ethyl-2,4,4-trimethylcyclohex-2-enylidene)methyl-4-substituted benzenes from 1-(2,6,6-trimethylcyclohex-1-enyl)ethanol
Das, B. C., Mahalingam, S. M., Evans, T., et al. (2009) · Chemical Communications · doi:10.1039/b823063c · Cited by 12
Disseminated Exfoliative Dermatitis Associated with All-Transretinoic Acid in the Treatment of Acute Promyelocytic Leukemia
Yönal, İ., Hulya, D., & Aktan, M. (2012) · Case Reports in Medicine · doi:10.1155/2012/236174 · Cited by 12

Authors: Muindi, J., Frankel, Sr., Miller, W. J., Jakubowski, A., Scheinberg, D., Young, C., Dmitrovsky, E., & Warrell, R. J.
Affiliations: Memorial Sloan Kettering Cancer Center (US)
Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10021.
ORCID: Jakubowski, A
Dmitrovsky, E
Venue: Blood
Publisher: American Society of Hematology
Published: 1992-01-15
Volume: 79
Issue: 2
Pages: 299-303
ISSN: 0006-4971 (ISSN-L)
1528-0020
DOI: 10.1182/blood.v79.2.299.299
OpenAlex: W4246713397
Cited by: 314
References: 0
Citations by year: 2026: 3 · 2025: 4 · 2024: 2 · 2023: 5 · 2022: 9 · 2021: 6 · 2020: 8 · 2019: 5 · 2018: 7 · 2017: 6 · 2016: 6 · 2015: 12 · 2014: 9 · 2012: 7
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: Blood (publishedVersion)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Retinoids in leukemia and cellular processes
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
Health Sciences › Medicine › Hematology › Acute Myeloid Leukemia Research
Keywords: all-trans retinoic acid, acute promyelocytic leukemia, relapse, drug resistance, plasma drug concentration, pharmacokinetics, leukemia cell differentiation, dose escalation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Continuous treatment with all-trans retinoic acid causes a progressive reduction in plasma drug concentrations: implications for relapse and retinoid "resistance" in patients with acute promyelocytic leukemia [published erratum appears in Blood 1992 Aug 1;80(3):855]

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks